Marketing Mix Of Alzheimer s Market Is Big Pharma Losing the Battle

Posted by Zander Henry on Aug-22-2018

1. marketing mix

1.1. Understanding the marketing mix

• The marketing mix is an important set of marketing tools and characteristics that a firm uses to increase penetration in the target market groups
• Using the marketing mix strategically includes focusing on seven important aspects of marketing and branding for an organization, namely: product, place, price, promotion, people, process, and physical evidence

1.2. Importance of marketing mix

• The marketing mix helps a company choose and decide on a suitable marketing strategy
• The marketing mix also helps a company in resource and budget allocation to different aspects of the marketing strategy and product development
• The marketing mix also allows a company to choose the right and effective marketing tactics for its promotional needs

2. Marketing mix for Alzheimer s Market Is Big Pharma Losing the Battle

Alzheimer s Market Is Big Pharma Losing the Battle makes use of the marketing mix strategically to achieve not only the marketing objectives but also the broader organizational objectives.

Marketing Mix Alzheimer s Market Is Big Pharma Losing the Battle is presented below:

2.1. Product

Product is one of the most important components of the Alzheimer s Market Is Big Pharma Losing the Battle Marketing mix. The distinctive characteristics of the product by Alzheimer s Market Is Big Pharma Losing the Battle are:

2.1.1. Quality

• Alzheimer s Market Is Big Pharma Losing the Battle maintains the high quality of products
• High product quality is maintained by adding value during different stages of the value chain
• Alzheimer s Market Is Big Pharma Losing the Battle procures raw materials from reliable and trusted suppliers only
• These raw materials are processed under carefully maintained environments to maintain high and consistent quality of the products
• High quality promise and delivery also provides Alzheimer s Market Is Big Pharma Losing the Battle with a distinctive competitive advantage

2.1.2. Ease of use

• The products manufactured and sold by Alzheimer s Market Is Big Pharma Losing the Battle are relatively easy to use
• All products come with a user manual, which is easy to understand and which provides simple instructions for product use
• The consumers can also call the 24/7 helpline to understand details about product usage
• Also, retail representatives provide detailed instructions and explanations regarding the use of the product at the time of the sale

2.1.3. Portfolio broadness

• Alzheimer s Market Is Big Pharma Losing the Battle has a broad portfolio of products
• The broad portfolio helps Alzheimer s Market Is Big Pharma Losing the Battle in reaching different target groups in the market
• Also, the broad portfolio allows financial strength to Alzheimer s Market Is Big Pharma Losing the Battle
• The broader product portfolio also adds more value for Alzheimer s Market Is Big Pharma Losing the Battle

2.1.4. Benefits of product consumption

• Alzheimer s Market Is Big Pharma Losing the Battle offers functional benefits to consumers of the product use
• These functional benefits are promised and delivered – however, they are also delivered by other similar products
• The distinguishing aspect of Alzheimer s Market Is Big Pharma Losing the Battle is its delivery of emotional benefits to the consumer
• Products manufactured and sold by Alzheimer s Market Is Big Pharma Losing the Battle promise consumers an ego boost, confidence, and security
• Alzheimer s Market Is Big Pharma Losing the Battle also promises fulfilment of psychological needs on product consumption
• These psychological needs include, for example, the need for empathy, the need for belonging, and the need of feeling loved.

2.1.5. Different SKUs

• The products by Alzheimer s Market Is Big Pharma Losing the Battle are available in different sizes
• Alzheimer s Market Is Big Pharma Losing the Battle has made use of different SKUs to increase market penetration
• Different SKUs can be brought and used as per the consumption needs of the consumers, and the target markets
• Through the production of different SKUs, Alzheimer s Market Is Big Pharma Losing the Battle has also increased the trial rate
• Different SKUs have also helped Alzheimer s Market Is Big Pharma Losing the Battle improve its product accessibility

2.2. Price

Alzheimer s Market Is Big Pharma Losing the Battle marketing mix focuses on a hybrid strategy for pricing to obtain maximum value for its products. The marketing mix Alzheimer s Market Is Big Pharma Losing the Battle uses a combination of a number of techniques for pricing its products, which are detailed below:

2.2.1. Premium pricing

• By using premium pricing for some of its product ranges, Alzheimer s Market Is Big Pharma Losing the Battle encourages favorable brand and product perceptions in target consumer groups
• Premium pricing for products also encourages a favorable quality perception of Alzheimer s Market Is Big Pharma Losing the Battle products amongst consumers
• With premium prices, Alzheimer s Market Is Big Pharma Losing the Battle has successfully also made some of its product ranges exclusive by restricting sales and production. This, in turn, leads to a perception g luxury in consumption products
• Premium prices add a touch of privilege and high value in Alzheimer s Market Is Big Pharma Losing the Battle products
• Using elements of premium prices in other product ranges has also allowed Alzheimer s Market Is Big Pharma Losing the Battle to maintain significantly high profits and a consistent business growth

2.2.2. Psychological pricing

• Since Alzheimer s Market Is Big Pharma Losing the Battle has a number of different product ranges and product groups, the use of psychological pricing has been beneficial
• With the use of psychological pricing, Alzheimer s Market Is Big Pharma Losing the Battle also successfully adds more value to its products from the point of view of customers
• Alzheimer s Market Is Big Pharma Losing the Battle also gains higher sales with psychological pricing
• Consumer purchase a higher amount of Alzheimer s Market Is Big Pharma Losing the Battle products because of its use of psychological pricing
• Alzheimer s Market Is Big Pharma Losing the Battle is able to increase its target audience and broaden its target purchaser groups

2.2.3. Geographical pricing

• Alzheimer s Market Is Big Pharma Losing the Battle is able to penetrate different regional markets optimally with the use of geographical pricing
• For offshore locations, geographical pricing also allows Alzheimer s Market Is Big Pharma Losing the Battle to cover shipping and customs expenses
• Geographical pricing also allows Alzheimer s Market Is Big Pharma Losing the Battle to maintain consistent revenue growth by altering pricing in different markets based on local currency value

2.2.4. Bundle pricing

• For some product ranges, Alzheimer s Market Is Big Pharma Losing the Battle is also known to use bundle pricing strategy popularly
• Alzheimer s Market Is Big Pharma Losing the Battle also uses bundle pricing during sales
• Bundle pricing increases the trial rate for consumers
• Alzheimer s Market Is Big Pharma Losing the Battle experiences higher return on the cost of gaining a new customer
• With bundle pricing, Alzheimer s Market Is Big Pharma Losing the Battle is also able to control costs and prices by lowering marketing and distribution expenses
• The use of bundle pricing also adds value to the umbrella brand name of Alzheimer s Market Is Big Pharma Losing the Battle.

2.3. Placement

Alzheimer s Market Is Big Pharma Losing the Battle places high importance on the placement of its products because it directly relates to accessibility for consumers.

2.3.1. Company-operated stored

• The company maintains stores operated by the management of Alzheimer s Market Is Big Pharma Losing the Battle in all markets
• Company-operated stores give Alzheimer s Market Is Big Pharma Losing the Battle higher control over operations as well as store layout and design
• Alzheimer s Market Is Big Pharma Losing the Battle also interacts directly with the consumers and gathers important details regarding consumer behavior and consumer feedback through company-operated stores
• The company operated stores also give leverage to Alzheimer s Market Is Big Pharma Losing the Battle in terms of decisions regarding the stocking of different product items

2.3.2. Licensed stores

• Alzheimer s Market Is Big Pharma Losing the Battle licensed stores also allow consumers to enjoy the various product offerings by the company
• Licensed stores also decrease the risk of financial and physical investment for Alzheimer s Market Is Big Pharma Losing the Battle in unstable markets
• Licensed stores have also given Alzheimer s Market Is Big Pharma Losing the Battle high business growth, and a boost for rapid market expansion and penetration
• Through licensed stores, Alzheimer s Market Is Big Pharma Losing the Battle has also learned about local consumers and cultures
• Licensed stores and shops encourage sales of products by Alzheimer s Market Is Big Pharma Losing the Battle by aligning it with local cultural values
• Licensed stores also help Alzheimer s Market Is Big Pharma Losing the Battle in localizing its product offerings to enhance brand equity and band image

2.3.3. E-commerce

• Alzheimer s Market Is Big Pharma Losing the Battle has developed a successfully operational website for online order placement and order tracking
• Alzheimer s Market Is Big Pharma Losing the Battle also encourages sales through social media portals, where the company takes orders through direct messages, as well as through a mini-shop model
• The company also stocks products with online retailers such as Amazon and eBay, as well as smaller local online retailers as well
• Online retailing, and using the internet to make sales has boosted the sales for Alzheimer s Market Is Big Pharma Losing the Battle and has also increased the accessibility of its products for consumers.

2.3.4. Supermarkets and hypermarkets

• Alzheimer s Market Is Big Pharma Losing the Battle also places its products in supermarkets and hypermarkets across the country
• A large number of Alzheimer s Market Is Big Pharma Losing the Battle target groups shop from supermarkets and hypermarkets
• Placement in supermarkets and hypermarkets also improve cost efficiency for Alzheimer s Market Is Big Pharma Losing the Battle

2.3.5. Partner agents

• In offshore locations, Alzheimer s Market Is Big Pharma Losing the Battle also makes use of partner agents for its products’ placement
• These partner agents are assessed and evaluated on strategic compatibility and reliance
• Alzheimer s Market Is Big Pharma Losing the Battle contracts with partner agents in other countries and markets for its product placement to ensure quality control and terms of negotiation

2.4. Promotion

The marketing strategy for Alzheimer s Market Is Big Pharma Losing the Battle also places high importance on the promotional tactics and strategies used. The promotional strategies allow the Alzheimer s Market Is Big Pharma Losing the Battle to interact with the consumers and influence them directly. Alzheimer s Market Is Big Pharma Losing the Battle uses a 360-degree approach in its promotional activities, and makes use of the following means of promotion:

2.4.1. Digital marketing

• Alzheimer s Market Is Big Pharma Losing the Battle has corporate profiles on all social media websites and portals
• Alzheimer s Market Is Big Pharma Losing the Battle uses its social media presence to directly, engage with consumers
• This direct engagement and interaction allows Alzheimer s Market Is Big Pharma Losing the Battle to understand the customers, their needs and demands
• Alzheimer s Market Is Big Pharma Losing the Battle uses this feedback and incorporates it in its broader marketing and organizational strategy
• Alzheimer s Market Is Big Pharma Losing the Battle also maintains a corporate website – which highlights company information, product information as well as information regarding any ongoing campaigns and sales

2.4.2. Reward Programs

• Alzheimer s Market Is Big Pharma Losing the Battle has a loyalty card program for its customers
• The loyalty card allows customers to redeem points in exchange for products or other exciting gifts, as directed by the company
• Each purchase is entered into the loyalty card by Alzheimer s Market Is Big Pharma Losing the Battle and is valued for points against the products’ monetary value
• The loyalty card can be purchased or is given complementary by Alzheimer s Market Is Big Pharma Losing the Battle on high valued purchases
• Frequent usage and purchase of products by Alzheimer s Market Is Big Pharma Losing the Battle also has rewards against the loyalty card

2.4.3. Community Influencers

• Alzheimer s Market Is Big Pharma Losing the Battle makes use of community influencers as its on-ground promotional efforts
• Alzheimer s Market Is Big Pharma Losing the Battle identifies strong and confident individuals to be brand ambassadors in their communities
• Alzheimer s Market Is Big Pharma Losing the Battle provides these brand ambassadors and community influencers with its product range and invites them to use it themselves to see benefits

2.4.4. Conventional marketing

• The company places advertisements in consumer-related magazines. This largely includes home decor, and home management magazines
• Magazine ads are not very frequent, but appear twice every quarter of the fiscal year
• In high-density locations, Alzheimer s Market Is Big Pharma Losing the Battle also makes use of out of house hoardings
• Hoardings increase visibility for Alzheimer s Market Is Big Pharma Losing the Battle and also work towards building stronger brand recall
• Alzheimer s Market Is Big Pharma Losing the Battle also produces TV advertisements
• All TV advertisements have an emotional appeal to them
• TV advertisements by Alzheimer s Market Is Big Pharma Losing the Battle have progressed to include a slice of life elements and characteristics
• TV advertisements by Alzheimer s Market Is Big Pharma Losing the Battle also highlight the functional benefits of the product

2.5. People

The marketing mix of Alzheimer s Market Is Big Pharma Losing the Battle also places an essential focus on people development and people building. This is because Alzheimer s Market Is Big Pharma Losing the Battle realizes the importance of employees in building strong customer relationships. Alzheimer s Market Is Big Pharma Losing the Battle develops its employee and people by focusing on the following aspects:

2.5.1. Training

• Alzheimer s Market Is Big Pharma Losing the Battle makes sure that all employees undergo regular training sessions for skill development and enhancement
• Trainings at Alzheimer s Market Is Big Pharma Losing the Battle are not the only field related, but also focus on essential management and organizational skills
• Training sessions and activities at Alzheimer s Market Is Big Pharma Losing the Battle also identify with the employee's own needs of progression, development and growth
• All training sessions and activities designed and carried out by Alzheimer s Market Is Big Pharma Losing the Battle take into consideration business goals and objectives, as well as employee's personal goals and aspirations
• Alzheimer s Market Is Big Pharma Losing the Battle, therefore, tries to develop the employee as an organizational member, as well as an individual
• All training is engaging, and hands-on so that employees do not only learn but also experience

2.5.2. Organizational ownership

• Alzheimer s Market Is Big Pharma Losing the Battle works on strengthening the organizational commitment in its employees
• Alzheimer s Market Is Big Pharma Losing the Battle builds employee loyalty so that people can reflect their optimal best at work
• Alzheimer s Market Is Big Pharma Losing the Battle also understands that satisfied employees will lead to happy and satisfied customers
• Alzheimer s Market Is Big Pharma Losing the Battle regularly shares different reward programs for employees, including stock sharing, so that their organizational commitment and ownership is enhanced
• Alzheimer s Market Is Big Pharma Losing the Battle also includes employees in decision making at different managerial levels, and regularly takes their feedback for different projects and products – which also work towards building organizational ownership

2.5.3. Motivation building

• Alzheimer s Market Is Big Pharma Losing the Battle employees are the face of the organization
• Alzheimer s Market Is Big Pharma Losing the Battle are motivated through the exciting and creative organizational culture
• Employees are also motivated through different reward programs and bonuses that Alzheimer s Market Is Big Pharma Losing the Battle distributes
• Another source of motivation is appreciation programs where management appreciates and acknowledges the work and performance of different employees

2.5.4. Succession planning

• Alzheimer s Market Is Big Pharma Losing the Battle remains one of the leading players in the industry also because of its focus on succession planning
• Alzheimer s Market Is Big Pharma Losing the Battle conducts succession planning for all managerial levels
• Succession planning is done through internal promotions as well as external recruitments to meet the needs and demands of the vacant job position at Alzheimer s Market Is Big Pharma Losing the Battle
• Strategic succession planning has allowed Alzheimer s Market Is Big Pharma Losing the Battle to be prepared for different challenges, and also be resourceful enough to deflect them

2.6. Process

Alzheimer s Market Is Big Pharma Losing the Battle has organized and systematic processes in place to make sure that the business experiences consistent growth.

2.6.1. Operations

• All operations at Alzheimer s Market Is Big Pharma Losing the Battle are clearly defined and communicated to the employees
• Alzheimer s Market Is Big Pharma Losing the Battle makes sure that employees are well trained, and knowledgeable of all processes relates to operations
• All stages of operational processes focus on maintaining a high quality level and standard of the products
• Systematic process re in place for all operation – from procurement to the final sale of the products
• All operational processes are maintained, checked, and uploaded through the internal portal of the organization for supervisory purposes
• The use of online portals for operational processes also builds a strong backup for managerial purposes at Alzheimer s Market Is Big Pharma Losing the Battle

2.6.2. People Management

• Alzheimer s Market Is Big Pharma Losing the Battle has also defined clear processes for people management through streamlining its human resource management department
• Alzheimer s Market Is Big Pharma Losing the Battle has defined guidelines regarding recruitment, training, compensation management, and performance appraisal of employees
• All people related processes are not only communicated to the management and supervisors, but also to employees to create a sense of transparency, and an environment of trust
• Progressive people management systems and processes have allowed Alzheimer s Market Is Big Pharma Losing the Battle to keep its workforce motivated and happy – which reflects in satisfied customers

2.6.3. Quality maintenance

• Alzheimer s Market Is Big Pharma Losing the Battle also has defined policies and processes for managing and maintaining quality
• All products undergo triple quality checks to ensure that customers receive the best product
• In addition to quality checks at the production and distribution level, the management has also placed separate quality maintenance and quality check department
• The quality maintenance department has experts who make sure that not only the final product but also the processes involved in producing the product were infused with quality

2.6.4. Store management

• Alzheimer s Market Is Big Pharma Losing the Battle manages store management through stringent and closely monitored policies and processes
• These processes relate to not only the floor and space design but also to the performance of the employees at the store
• The processes for store management also regularly monitor footfall and work on strategies to increase footfall through different tactics, and changes in the store design and store management
• The company also has a systematic process for customers who interact with the products and feel them before making the purchase
• The final sale at the store is also clearly defined – for the employees and the customers both
• Processes and policies are important for Alzheimer s Market Is Big Pharma Losing the Battle for maintaining quality of the products, and for ensuring that the company does not experience any unnecessary expenses and costs

2.7. Physical evidence

The physical evidence is also important in the marketing strategy for Alzheimer s Market Is Big Pharma Losing the Battle as it works towards influencing the consumers in favor of the brand and its offerings. The physical evidence for Alzheimer s Market Is Big Pharma Losing the Battle include:

2.7.1. Store atmosphere

• The store design and management for Alzheimer s Market Is Big Pharma Losing the Battle is exciting and creative
• The store atmosphere makes the customers feel relaxed and comfortable –so that they can interact with, and enjoy product offerings by Alzheimer s Market Is Big Pharma Losing the Battle at ease
• The store design is also important for Alzheimer s Market Is Big Pharma Losing the Battle because it controls the level and nature of experience and interaction that the customers have with the product and the brand
• With company-operated stores, it is easier for Alzheimer s Market Is Big Pharma Losing the Battle to control and manage the store atmosphere to be able to positively influence customers and to be able to appeal to them emotionally

2.7.2. Packaging

• Alzheimer s Market Is Big Pharma Losing the Battle has unique packaging, which is different from other players in the industry
• Alzheimer s Market Is Big Pharma Losing the Battle also has a vibrant touché to its packaging, which is regularly changed in terms of colors and patterns
• The logo for the company is simple, and recognizable by the consumers easily
• The brand logo has also become a symbol of confidence, ambition, and aspiration for consumers who use products by Alzheimer s Market Is Big Pharma Losing the Battle
• The packaging of the products is sophisticatedly done and matches the brand image developed and maintained by Alzheimer s Market Is Big Pharma Losing the Battle

2.7.3. Website design

• The website design is simple and easy to use
• Alzheimer s Market Is Big Pharma Losing the Battle has a customer friendly user interface which allows easy navigation and understanding of its various product offerings
• The corporate website of Alzheimer s Market Is Big Pharma Losing the Battle also has the brand logo, and is packaged similarly to the products offered by the company
• The design patterns, and color change on the website with changes to the product packaging to match various campaign needs and sale offerings